About COUP transcription factor 1
COUP transcription factor 1 (NR2F1) is a protein
from Homo sapiens identified by UniProt accession
P10589, 423 residues long.
MolForge cross-references it against 0 known binders and
206 disease associations.
Target properties
| Protein name | COUP transcription factor 1 |
| UniProt accession | P10589 |
| Gene | NR2F1 |
| Organism | Homo sapiens |
| Length | 423 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (206)
Diseases linked to this target (Open Targets).
- Bosch-Boonstra-Schaaf optic atrophy syndrome · score 0.79
- Optic atrophy-intellectual disability syndrome · score 0.72
- genetic disorder · score 0.52
- neurodegenerative disease · score 0.50
- mathematical ability · score 0.43
- Neurodevelopmental delay · score 0.41
- diet measurement · score 0.37
- cortical thickness · score 0.36
- self reported educational attainment · score 0.36
- brain volume measurement · score 0.36
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P10589-F1 | alphafold | PREDICTED | 75.28 | — |
Amino-acid sequence (423 residues)
MAMVVSSWRD PQDDVAGGNP GGPNPAAQAA RGGGGGAGEQ QQQAGSGAPH TPQTPGQPGA PATPGTAGDK GQGPPGSGQS QQHIECVVCG DKSSGKHYGQ FTCEGCKSFF KRSVRRNLTY TCRANRNCPI DQHHRNQCQY CRLKKCLKVG MRREAVQRGR MPPTQPNPGQ YALTNGDPLN GHCYLSGYIS LLLRAEPYPT SRYGSQCMQP NNIMGIENIC ELAARLLFSA VEWARNIPFF PDLQITDQVS LLRLTWSELF VLNAAQCSMP LHVAPLLAAA GLHASPMSAD RVVAFMDHIR IFQEQVEKLK ALHVDSAEYS CLKAIVLFTS DACGLSDAAH IESLQEKSQC ALEEYVRSQY PNQPSRFGKL LLRLPSLRTV SSSVIEQLFF VRLVGKTPIE TLIRDMLLSG SSFNWPYMSI QCS
Explore COUP transcription factor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets